Cannabinoid CB1 Receptor Expression in Rat Spinal Cord

Farquhar-Smith, W.Paul, Egertová, Michaela, Bradbury, Elizabeth J., McMahon, Stephen B., Rice, Andrew S.C., Elphick, Maurice R.·2000·Molecular and Cellular Neuroscience
DOI 10.1006/mcne.2000.0844

Cited by (269)

Items 201–269 of 269

  1. Mechanisms of Plasticity of Inhibition in Chronic Pain Conditions
    Charalampos Labrakakis, Francesco Ferrini, Yves De Koninck · 2010 · Springer eBooks
  2. Cannabinoid Receptor Genetics and Evolution
    Maurice R. Elphick, Michaela Egertová · 2008 · The Receptors
  3. Cancer pain syndromes
    Robert Twycross, Mike Bennett · 2008 · CRC Press eBooks
  4. Sex‐specific characteristics of cells expressing the cannabinoid 1 receptor in the dorsal horn of the lumbar spinal cord
    Yulin Zhang, Jin Ke, Yuan Zhou, Xue Liu, Tianwen Huang, Liping Wang · 2022 · The Journal of Comparative Neurology
  5. Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level
    Diana Spicarova, Jiřı́ Paleček · 2024 · Physiological Research
  6. Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists
    Priyadharishini Veeraraghavan, Andrea Nistri · 2015 · Neuroscience
  7. Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats
    Beata Kopczyńska · 2008 · Life Sciences
  8. Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets
    Fatemeh Aghamahdi, Arman Shafiee, Sayeh Rostami, Zakiye Mokhames, Mahshid Safavi, Somayeh Yaslianifard, Zeinab Siami, Kourosh Kabir, Gholamreza Azizi, Mahmood Bakhtiyari et al. · 2022 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  9. Dual effect of anandamide on spinal nociceptive transmission in control and inflammatory conditions
    Monica Pontearso, Jakub Slepicka, Anirban Bhattacharya, Diana Spicarova, Jiřı́ Paleček · 2024 · Biomedicine & Pharmacotherapy
  10. Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit
    Rob W. Clarke, John E. Harris, Sam Jenkins, S.K Witton · 2001 · Neuropharmacology
  11. Canonical Cannabinoid Receptors
    Beth Ehrlich, Monica Patel, Xiaoxi Zheng, Michelle Glass · 2024 · Current topics in behavioral neurosciences
  12. Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
    Diana Spicarova, Vladimír Nerandžič, David Muzik, Monica Pontearso, Anirban Bhattacharya, I. Nagy, Jiřı́ Paleček · 2023 · Frontiers in Molecular Neuroscience
  13. Regulation of Cannabinoid and Opioid Receptor Levels by Endogenous and Pharmacological Chaperones
    Achla Gupta, Ivone Gomes, Aya Osman, Wakako Fujita, Lakshmi A. Devi · 2024 · Journal of Pharmacology and Experimental Therapeutics
  14. Functional Organization of Dorsal Horn Interneurons
    William D. Willis, Richard E. Coggeshall · 2004 · Springer eBooks
  15. Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists
    Brian F. Thomas · 2009 · Drug Development Research
  16. The anti-apoptotic activity associated with phosphatidylinositol transfer protein α activates the MAPK and Akt/PKB pathway
    Martijn Schenning, Joachim Goedhart, Theodorus W. J. Gadella, Diana Avram, KAREL W. A. WIRTZ, Gerry T. Snoek · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  17. Spinal dorsal horn neurons involved in the alleviating effects of cannabinoid receptor agonists on neuropathic allodynia-like behaviors in rats
    Daichi Sueto, Eriko I, Akihisa Onishi, Makoto Tsuda · 2025 · Journal of Pharmacological Sciences
  18. A systematic review of how cannabinoids affect motoneuron output
    Elijah M. K. Haynes, Jayne M. Kalmar, Mathew Vis‐Dunbar, Kathryn M. Crosby, Angitha Mriduraj, Jennifer M. Jakobi · 2023 · Journal of Neurophysiology
  19. Effects of intrathecal anandamide on somatosensory evoked responses in rats
    Levent Sinan Bir, Sevim Z. Ercan · 2005 · Experimental Neurology
  20. Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs
    Vincenzo Di Marzo, Tiziana Bisogno, Luciano De PETROCELLIS · 2001 · Expert Opinion on Therapeutic Targets
  21. Interspecies differences in the expression of cannabinoid receptors at the tissue and cellular levels
    Sydney Lawley, Audrey Green, Cole Johnson, Michael D. Burton · 2025 · Neural Regeneration Research
  22. Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons
    Yasuhiko Kawasaki, Tsugumi Fujita, Kun Yang, Eiichi Kumamoto · 2015 · Pharmacology &amp Pharmacy
  23. Glial Modulation in Pain States: Translation into Humans
    Ryan J. Horvath, Edgar Alfonso Romero-Sandoval, Joyce A. De Leo · 2010 · Europe PMC (PubMed Central)
  24. Recent data on cannabinoids and their pharmacological implications in neuropathic pain.
    Oana Andreia Coman, Horia Păunescu, Laurențiu Coman, A Bădărău, Ion Fulga · 2008 · PubMed Central
  25. A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro
    Priyadharishini Veeraraghavan, Ana Dekanic, Andrea Nistri · 2016 · Neuroscience
  26. The Endogenous Cannabinoid System: A Cadre of Potential Therapeutic Targets
    Steven G. Kinsey, Aron H. Lichtman · 2018 · Springer eBooks
  27. CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat Spinal Dorsal Horn Neurons
    Jingdong Long, Xiaolu Lei, Meiyun Chen, Shulei Yang, Tao Sun, Junwei Zeng, Yu Deqian, Hong Wei Tian, Xiaohong Liu · 2017 · Neurochemical Research
  28. Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome
    Mikhail Lvovich Kukushkin, S. I. Igon’kina, Maxim V. Churyukanov, V. V. Churyukanov, М. Yu. Bobrov, В. В. Безуглов, Nataliya Gretskaya · 2006 · Bulletin of Experimental Biology and Medicine
  29. Endocannabinoid Mechanisms of Pain Modulation
    Andrea G. Hohmann, Richard L. Suplita · 2008 · Springer eBooks
  30. Negative allosteric modulation of cannabinoid CB 1 receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception
    Vishakh Iyer, Shahin A. Saberi, Romario Pacheco, Emily Fender Sizemore, Sarah Stockman, Abhijit Kulkarni, Lucas Cantwell, Ganesh A. Thakur, Andrea G. Hohmann · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Review of Neuraxial Agents Producing Analgesia
    Elayne Vieira Dias, Linda S. Sorkin, Tony L. Yaksh · 2023 · Springer eBooks
  32. 20:4-NAPE induced changes of mechanical sensitivity and DRG neurons excitability are concentration dependent and mediated via NAPE-PLD
    Anirban Bhattacharya, Daniel Vasconcelos, Diana Spicarova, Jiřı́ Paleček · 2025 · Scientific Reports
  33. The endocannabinoid system regulates both ependymoglial and neuronal cell responses to a tail amputation in the axolotl
    Michael Tolentino, Sarah E. Walker, Gaynor E. Spencer, Robert L. Carlone · 2025 · Developmental Dynamics
  34. Pharmacotherapy of chronic orofacial pain
    Rafael Benoliel, Yair Sharav · 2008 · Elsevier eBooks
  35. Endocannabinoids and vanilloid TRPV1 receptors
    Ruth A. Ross · 2005 · Birkhäuser Basel eBooks
  36. Cannabinoids and Pruritus
    Sonja Alexandra Grundmann, Sonja Ständer · 2009 · Basic and clinical dermatology
  37. The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation
    A. Matthew Reck, David Peter Siderovski, Steven G. Kinsey · 2024 · Neuropharmacology
  38. Emerging therapeutic strategies for chronic pain
    Mark Abrahams, Rajesh Munglani · 2000 · Emerging Drugs
  39. Neuropathic pain : glial responses and plasticity in the spinal nociceptive network
    Robby J.P. Jaken · 2010
  40. The Cannabinoid 1 Receptor and Progenitor Cells in the Adult Central Nervous System
    Alexandra Sideris, Thomas J. J. Blanck, Esperanza Recio‐Pinto · 2012 · InTech eBooks
  41. Endocannabinoidi e Fitocannabinoidi nel Cancro
    Alessia Ligresti · 2006 · Università degli Studi di Napoli Federico II
  42. The effect of plant derived and endogenous substances on the spinal mechanisms of pain in rats
    Ibolya G. Farkas · 2011
  43. Study for the Antinociceptive Effect and Toxicity of Chronic Intrathecal Infusion of Cannabinoids in Rats
    Myung Ha Yoon, Hong Buem Bae, Jeong Il Choi, Chun Sang Bae, Seok Jae Kim, Chang Mo Kim, Sung Tae Jeong, Kwang Su Kim, Won Jong Jin, Jong Pil Kim et al. · 2005 · The Korean journal of pain
  44. Modulation of spinal pain processing by cannabinoid receptor agonists
    M. V. Churukanov · 2006 · Neurophysiology
  45. Vascular actions of oleamide in health and disease
    Jamie J. Hopps · 2013 · Nottingham ePrints (University of Nottingham)
  46. Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?
    Jay J. Paquette · 2007
  47. Caracterização da hemopressina (agonista inverso de receptores canabinóides do tipo 1) na neuropatia diabética experimental.
    Elaine F. Toniolo · 2015
  48. Vanilloïdes, cannabinoïdes et nociception: aspects anatomiques
    Marie Conrath, Judith Fischer, Chiara Salio, Maria Fosca Franzoni, Stéphane Doly · 2001 · Douleur et Analgésie
  49. Modulation of nociceptive transmission by cannabinoids in the spinal dorsal horn
    Yasuhiko Kawasaki, Kun Yang, Tsugumi Fujita, Ceng Luo, Eiichi Kumamoto · 2003 · PAIN RESEARCH
  50. Review Arthritis and pain: Neurogenic origin of joint pain
    Jason J. McDougall · 2006
  51. Cannabinoids and Pruritus
    Sonja Alexandra Grundmann · 2016
  52. Basic Science of Spinal Receptors
    Jeffrey S. Kroin, Asokumar Buvanendran · 2012 · Elsevier eBooks
  53. Efeitos antinociceptivo e anti-inflamatório da eletroacupuntura na artrite induzida por zymosan na articulação temporomandibular de ratos : participação do sistema endocanabinóide
    Delane Viana Gondim · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  54. Design, synthesis, methodology development, and evaluation of PET imaging agents targeting cancer and CNS disorders
    Gengyang Yuan · 2017
  55. Role of the Cannabinoid System in Modulating the Reinforcing and Relapse Related Properties of Nicotine in Rats
    Islam Gamaleddin · 2013 · TSpace (University of Toronto)
  56. 1 Different Effects of Opioid and Cannabinoid Receptor Agonists on C-fiber-Induced ERK Activation in Dorsal Horn Neurons in Normal and Spinal Nerve-Ligated Rats
    Yasuhiko Kawasaki, Tatsuro Kohno, Ru‐Rong Ji · 2016
  57. Applied physiology: neuropathic pain
    Victoria C. J. Wallace, Andrew S.C. Rice · 2008 · CRC Press eBooks
  58. Canabinoides
    Andrew S.C. Rice · 2007 · Elsevier eBooks
  59. Modulation of Cannabinoid Receptor Activity by Allosteric Modulators, Inverse Agonists and Receptor Binding Partners
    Mariam M. Mahmoud · 2015 · OpenCommons at University of Connecticut (University of Connecticut)
  60. Cannabinoids
    Andrew S.C. Rice · 2006 · Elsevier eBooks
  61. Therapeutic implications of the endocannabinoid system in neurodegenerative diseases
    Andy Goren, University of Rome "G.Marconi" · 2015 · Clinical Case Reports and Reviews
  62. Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Human and Rat Spinal Cord Tissue
    Jessica Parnell · 2022
  63. FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
    Nicole Boury‐Esnault, Christian Marschal, Probst, Jean-Michel Korn-, Gilles Barnathan · 2002 · INFM-OAR (INFN Catania)
  64. Implication of astrocytes in NMDA-dependent modulation of spinal inhibition
    Louise Vial-Markiewicz · 2023
  65. Cannabinoids in Motor Control: From Receptor Distribution to Motor Disorders
    Dan Faganeli, Metoda Lipnik‐Štangelj · 2026 · Biomedicines
  66. Distribution and subacute modulation of endocannabinoid metabolizing enzymes in the trigeminal complex and midbrain in a pre-clinical model of post-traumatic headache
    Gurueswar Nagarajan, Yumin Zhang · 2026 · The Journal of Headache and Pain
  67. Nociceptor-restricted cannabinoid receptor 1 contributes to chronic but not acute analgesia
    Amber L. Milligan, Audrey R Green, Katherine M. Garner, Thomas A. Szabo-Pardi, Luz R. Barron, Dana M. Jenkins, Carlos M. Castorena, Joel Keith Elmquist, Michael D. Burton · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  68. BindingDB Entry 50013458: From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.
    BindingDB · 2022 · UC San Diego
  69. BindingDB Entry 50019281: N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).
    BindingDB · 2024 · UC San Diego